Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 248

1.

A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence.

Winhusen T, Somoza E, Ciraulo DA, Harrer JM, Goldsmith RJ, Grabowski J, Coleman FS, Mindrum G, Kahn R, Osman S, Mezinskis J, Li SH, Lewis D, Horn P, Montgomery MA, Elkashef A.

Drug Alcohol Depend. 2007 Dec 1;91(2-3):141-8. Epub 2007 Jul 16.

PMID:
17629631
2.

A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence.

Winhusen T, Somoza E, Sarid-Segal O, Goldsmith RJ, Harrer JM, Coleman FS, Kahn R, Osman S, Mezinskis J, Li SH, Lewis D, Afshar M, Ciraulo DA, Horn P, Montgomery MA, Elkashef A.

Drug Alcohol Depend. 2007 Dec 1;91(2-3):205-12. Epub 2007 Jul 12.

PMID:
17628352
3.

A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments.

Winhusen TM, Somoza EC, Harrer JM, Mezinskis JP, Montgomery MA, Goldsmith RJ, Coleman FS, Bloch DA, Leiderman DB, Singal BM, Berger P, Elkashef A.

Addiction. 2005 Mar;100 Suppl 1:68-77.

PMID:
15730351
4.

A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence.

Reid MS, Casadonte P, Baker S, Sanfilipo M, Braunstein D, Hitzemann R, Montgomery A, Majewska D, Robinson J, Rotrosen J.

Addiction. 2005 Mar;100 Suppl 1:43-57.

PMID:
15730349
5.

A placebo-controlled screening trial of celecoxib for the treatment of cocaine dependence.

Reid MS, Angrist B, Baker S, Woo C, Schwartz M, Montgomery A, Majewska D, Robinson J, Rotrosen J.

Addiction. 2005 Mar;100 Suppl 1:32-42.

PMID:
15730348
6.

Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.

McDowell D, Nunes EV, Seracini AM, Rothenberg J, Vosburg SK, Ma GJ, Petkova E.

Drug Alcohol Depend. 2005 Nov 1;80(2):209-21.

PMID:
15913920
7.

Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study.

Gonzalez G, Sevarino K, Sofuoglu M, Poling J, Oliveto A, Gonsai K, George TP, Kosten TR.

Addiction. 2003 Nov;98(11):1625-32.

PMID:
14616189
8.

The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study.

Pollack MH, Roy-Byrne PP, Van Ameringen M, Snyder H, Brown C, Ondrasik J, Rickels K.

J Clin Psychiatry. 2005 Nov;66(11):1401-8.

PMID:
16420077
9.

Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use.

Shoptaw S, Yang X, Rotheram-Fuller EJ, Hsieh YC, Kintaudi PC, Charuvastra VC, Ling W.

J Clin Psychiatry. 2003 Dec;64(12):1440-8.

PMID:
14728105
10.

Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence.

Ciraulo DA, Sarid-Segal O, Knapp CM, Ciraulo AM, LoCastro J, Bloch DA, Montgomery MA, Leiderman DB, Elkashef A.

Addiction. 2005 Mar;100 Suppl 1:12-22.

PMID:
15730346
11.

Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.

Elkashef A, Holmes TH, Bloch DA, Shoptaw S, Kampman K, Reid MS, Somoza E, Ciraulo D, Rotrosen J, Leiderman D, Montgomery A, Vocci F.

Addiction. 2005 Mar;100 Suppl 1:91-101.

PMID:
15730353
12.

Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.

Ciraulo DA, Knapp C, Rotrosen J, Sarid-Segal O, Ciraulo AM, LoCastro J, Greenblatt DJ, Leiderman D.

Addiction. 2005 Mar;100 Suppl 1:23-31.

PMID:
15730347
13.

Open-label tiagabine monotherapy for major depressive disorder with anxiety.

Carpenter LL, Schecter JM, Tyrka AR, Mello AF, Mello MF, Haggarty R, Price LH.

J Clin Psychiatry. 2006 Jan;67(1):66-71.

PMID:
16426090
14.

A randomized, double-blind, placebo-controlled trial of long-acting risperidone in cocaine-dependent men.

Loebl T, Angarita GA, Pachas GN, Huang KL, Lee SH, Nino J, Logvinenko T, Culhane MA, Evins AE.

J Clin Psychiatry. 2008 Mar;69(3):480-6.

PMID:
18294021
15.

Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients.

González G, Desai R, Sofuoglu M, Poling J, Oliveto A, Gonsai K, Kosten TR.

Drug Alcohol Depend. 2007 Feb 23;87(1):1-9. Epub 2006 Aug 22.

PMID:
16930857
16.

A pilot trial of olanzapine for the treatment of cocaine dependence.

Kampman KM, Pettinati H, Lynch KG, Sparkman T, O'Brien CP.

Drug Alcohol Depend. 2003 Jun 5;70(3):265-73.

PMID:
12757964
17.

Tiagabine increases slow-wave sleep in a dose-dependent fashion without affecting traditional efficacy measures in adults with primary insomnia.

Walsh JK, Perlis M, Rosenthal M, Krystal A, Jiang J, Roth T.

J Clin Sleep Med. 2006 Jan 15;2(1):35-41.

PMID:
17557435
18.

A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence.

Johnson BA, Roache JD, Ait-Daoud N, Javors MA, Harrison JM, Elkashef A, Mojsiak J, Li SH, Bloch DA.

Drug Alcohol Depend. 2006 Oct 1;84(3):256-63. Epub 2006 May 2.

PMID:
16631323
19.

Olanzapine in cocaine dependence: a double-blind, placebo-controlled trial.

Hamilton JD, Nguyen QX, Gerber RM, Rubio NB.

Am J Addict. 2009 Jan-Feb;18(1):48-52. doi: 10.1080/10550490802544318.

PMID:
19219665
20.

Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment.

Connor KM, Davidson JR, Weisler RH, Zhang W, Abraham K.

Psychopharmacology (Berl). 2006 Jan;184(1):21-5. Epub 2005 Dec 10.

PMID:
16341846
Items per page

Supplemental Content

Write to the Help Desk